CMS Cardiac Rehabilitation Coverage for Chronic Heart Failure — NCD 359 Policy Update (2026)

CMS has issued a modification to National Coverage Determination (NCD) 359, which governs Medicare Part B coverage for Cardiac Rehabilitation (CR) programs—including the chronic heart failure (CHF) indication first established in 2014. If your practice or facility bills CR services to Medicare beneficiaries with stable CHF, this policy update is worth a close review to ensure your documentation, medical necessity criteria, and eligibility screening workflows remain aligned with current CMS requirements.

Field Detail
Payer CMS (Centers for Medicare & Medicaid Services)
Policy Cardiac Rehabilitation Programs for Chronic Heart Failure
Policy Code NCD 359
Change Type Modified
Effective Date 2026-03-12
Impact Level Medium
Specialties Affected Cardiology, Cardiac Rehabilitation, Internal Medicine, Heart Failure Programs
Key Action Audit patient eligibility documentation against the CHF-specific medical necessity criteria—LVEF ≤ 35%, NYHA Class II–IV, and stable status—before billing CR services to Medicare.

What CMS NCD 359 Covers: Cardiac Rehabilitation Program Basics

Under sections 1861(s)(2)(CC) and 1861(eee)(1) of the Social Security Act, Medicare Part B permits coverage for items and services furnished under an approved Cardiac Rehabilitation program. The regulatory framework at 42 CFR §410.49 defines program components, physician supervision standards, and session limits.

CMS has long covered CR for a defined list of cardiac conditions. Effective for dates of service on and after January 1, 2010, beneficiaries who have experienced any of the following qualify for standard CR coverage:

The CHF indication is separate—added through NCD authority under 42 CFR §410.49(b)(1)(vii)—and carries its own distinct eligibility criteria described in detail below.


The Chronic Heart Failure Indication: Medical Necessity Criteria Under NCD 359

Effective for dates of service on and after February 18, 2014, the Centers for Medicare & Medicaid Services determined that evidence was sufficient to extend CR coverage to beneficiaries with stable, chronic heart failure. This is not a blanket extension—CMS defined the covered population with precision, and every criterion matters for claims.

To qualify for CR services under the CHF indication, a beneficiary must meet all of the following:

1. Left Ventricular Ejection Fraction (LVEF) of 35% or less
The LVEF threshold is a hard clinical requirement. Documentation from echocardiography or another accepted imaging modality establishing LVEF ≤ 35% must be present in the medical record before CR services begin.

2. New York Heart Association (NYHA) Class II to IV Symptoms
The patient must have NYHA functional classification of II, III, or IV. Physician documentation of the NYHA classification—not just symptom description—should be explicitly stated in the referring clinician's notes.

3. Optimal Heart Failure Therapy for at Least Six Weeks
The beneficiary must have been on optimal heart failure therapy for a minimum of six weeks prior to initiating CR services. What constitutes "optimal" therapy will depend on current clinical guidelines, and the medical record must support that the treating physician considered and addressed guideline-directed medical therapy.

4. Stable Patient Status
CMS defines "stable" with specificity: the patient must not have had a major cardiovascular hospitalization or procedure within the preceding six weeks, and must not have a major cardiovascular hospitalization or procedure planned within the next six months. Both conditions apply simultaneously.

This stability definition has real claims implications. A patient who was hospitalized for decompensated heart failure five weeks ago is not eligible—even if all other criteria are met. Your referral intake process should include explicit screening for recent and planned hospitalizations.


What CMS Does Not Cover Under NCD 359

The non-coverage boundary here is straightforward but important to document correctly. Any cardiac indication that is not specifically identified in 42 CFR §410.49(b)(1)(vii) and is not otherwise covered in NCD 359 or another applicable NCD is considered non-covered under Medicare.

This means cardiac rehabilitation services furnished to beneficiaries with cardiac conditions outside the enumerated list—or CHF patients who do not meet the LVEF, NYHA, stability, and therapy duration criteria—will not be covered. Billing for non-qualifying patients creates both a claim denial risk and a potential overpayment liability.

There are no experimental or investigational designations within this NCD—coverage is either affirmatively granted under the defined criteria or non-covered by default.


Prior Authorization Requirements

NCD 359 does not establish a prior authorization requirement for cardiac rehabilitation services. However, billing teams should be aware that individual Medicare Advantage plans may impose prior authorization requirements above and beyond the NCD. If your patient population includes Medicare Advantage enrollees, verify plan-level PA requirements separately before initiating a CR program.


Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
Re-review every 24 monthsRe-review every 12 months with updated clinical documentation

Affected Codes

This policy does not list specific CPT or HCPCS codes. The NCD references CR program coverage broadly under 42 CFR §410.49 and the applicable Social Security Act provisions. For claims processing guidance and applicable billing codes, CMS directs to Transmittal 2989 (Medicare Claims Processing), available at the CMS website.

Billing teams should reference the CR-specific billing codes used under their existing claims processing workflows and confirm alignment with the Transmittal 2989 instructions. No ICD-10-CM codes are specified within the NCD document itself, but diagnosis coding for CHF (including specificity of systolic vs. diastolic dysfunction and acuity) must support the documented LVEF and NYHA criteria in the medical record.


This policy is now in effect (since 2026-03-12). Verify your claims match the updated criteria above.

What Your Billing Team Should Do

#Action Item
1

Audit your CHF referral intake checklist by March 12, 2026. Confirm it captures all four eligibility criteria: LVEF ≤ 35%, NYHA Class II–IV, six-plus weeks of optimal HF therapy, and stability screening (no major CV hospitalization or procedure within six weeks prior or six months planned). Any checklist that doesn't capture all four points creates documentation gaps.

2

Review medical records for active CHF patients already enrolled in CR. For ongoing cases, verify that the eligibility documentation in the chart would withstand a post-payment audit. If NYHA class or LVEF aren't explicitly documented by the referring physician, work with the clinical team to obtain a signed addendum before the next billing cycle.

3

Update your Medicare Advantage verification workflow. Because NCD 359 does not impose prior auth, but MA plans can, add a step to your pre-authorization process that checks CHF-specific CR prior auth requirements at the plan level—not just Medicare FFS policy.

+ 2 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee